Inventor of 4-disease drug gets a boost thanks to ISRAEL21c ISRAEL21c article on David Naor’s peptide drew a $5k investment and many reader inquiries. An Israeli biotech company is planning clinical studies.
One drug could treat Alzheimer’s, MS, Crohn’s and more A special peptide under development in Israel declares war against chronic inflammatory and neurodegenerative diseases.